China National Medicines Corporation Ltd. (SHA:600511)

Market Cap	22.90B
Revenue (ttm)	51.19B
Net Income (ttm)	2.16B
Shares Out	754.50M
EPS (ttm)	2.87
PE Ratio	10.58
Forward PE	9.50
Dividend	0.85 (2.81%)
Ex-Dividend Date	Jun 13, 2024

Volume	8,277,044
Average Volume	4,110,577
Open	30.96
Previous Close	30.86
Day's Range	30.05 - 30.97
52-Week Range	27.12 - 38.00
Beta	0.47
RSI	34.68
Earnings Date	Mar 20, 2025

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 3,138
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2023, SHA:600511's revenue was 49.70 billion, an increase of 9.23% compared to the previous year's 45.50 billion. Earnings were 2.15 billion, an increase of 9.26%.